Philip Cowie

504 total citations
10 papers, 163 citations indexed

About

Philip Cowie is a scholar working on Molecular Biology, Genetics and Pharmacology. According to data from OpenAlex, Philip Cowie has authored 10 papers receiving a total of 163 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Genetics and 2 papers in Pharmacology. Recurrent topics in Philip Cowie's work include Cancer Research and Treatments (2 papers), Epigenetics and DNA Methylation (2 papers) and Cannabis and Cannabinoid Research (2 papers). Philip Cowie is often cited by papers focused on Cancer Research and Treatments (2 papers), Epigenetics and DNA Methylation (2 papers) and Cannabis and Cannabinoid Research (2 papers). Philip Cowie collaborates with scholars based in United Kingdom, Italy and Canada. Philip Cowie's co-authors include Emma J. Raftis, Imke Mulder, Alasdair MacKenzie, M. I. Delday, Anna Ettorre, Delphine L. Caly, Scott Davidson, Peter McGuffin, Ruth A. Ross and Lynne Shanley and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Philip Cowie

10 papers receiving 162 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Cowie United Kingdom 7 93 35 32 26 22 10 163
Justus Ninnemann Germany 3 57 0.6× 9 0.3× 21 0.7× 23 0.9× 18 0.8× 4 117
Sarron Randall‐Demllo Australia 6 113 1.2× 11 0.3× 23 0.7× 15 0.6× 35 1.6× 8 217
Victoria Garib Austria 10 42 0.5× 13 0.4× 120 3.8× 11 0.4× 7 0.3× 17 310
Shujie Fu China 6 117 1.3× 9 0.3× 48 1.5× 10 0.4× 19 0.9× 11 260
Nicholas P. Dylla United States 6 90 1.0× 6 0.2× 18 0.6× 22 0.8× 16 0.7× 6 146
Nitharsshini Nirmalathasan France 4 153 1.6× 22 0.6× 53 1.7× 20 0.8× 8 0.4× 4 211
Karina Ratiner Israel 6 128 1.4× 10 0.3× 91 2.8× 12 0.5× 13 0.6× 6 210
Martino Tony Miele Italy 11 123 1.3× 36 1.0× 8 0.3× 10 0.4× 37 1.7× 20 273
Mary Abigail S. Garcia United States 4 118 1.3× 25 0.7× 38 1.2× 6 0.2× 18 0.8× 6 308
Nazlı Yalçınkaya Türkiye 8 151 1.6× 10 0.3× 14 0.4× 88 3.4× 35 1.6× 16 246

Countries citing papers authored by Philip Cowie

Since Specialization
Citations

This map shows the geographic impact of Philip Cowie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Cowie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Cowie more than expected).

Fields of papers citing papers by Philip Cowie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Cowie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Cowie. The network helps show where Philip Cowie may publish in the future.

Co-authorship network of co-authors of Philip Cowie

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Cowie. A scholar is included among the top collaborators of Philip Cowie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Cowie. Philip Cowie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Marini, Pietro, Philip Cowie, Ahmet Ayar, et al.. (2023). M3 Receptor Pathway Stimulates Rapid Transcription of the CB1 Receptor Activation through Calcium Signalling and the CNR1 Gene Promoter. International Journal of Molecular Sciences. 24(2). 1308–1308. 3 indexed citations
4.
Caly, Delphine L., et al.. (2019). The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant. Scientific Reports. 9(1). 801–801. 43 indexed citations
6.
Delday, M. I., Philip Cowie, Meenakshi Pradhan, et al.. (2018). Host-microbe interactions mediating antitumorigenic effects of MRX0518, a gut microbiota-derived bacterial strain, in breast, renal and lung carcinoma.. Journal of Clinical Oncology. 36(15_suppl). e15006–e15006. 13 indexed citations
7.
Cowie, Philip, et al.. (2015). The noncoding human genome and the future of personalised medicine. Expert Reviews in Molecular Medicine. 17. e4–e4. 11 indexed citations
8.
Davidson, Scott, Philip Cowie, Peter McGuffin, et al.. (2015). Analysis of the effects of depression associated polymorphisms on the activity of the BICC1 promoter in amygdala neurones. The Pharmacogenomics Journal. 16(4). 366–374. 14 indexed citations
9.
Hay, C. R. M., Lynne Shanley, Scott Davidson, et al.. (2014). Functional effects of polymorphisms on glucocorticoid receptor modulation of human anxiogenic substance-P gene promoter activity in primary amygdala neurones. Psychoneuroendocrinology. 47. 43–55. 15 indexed citations
10.
Cowie, Philip, Ruth A. Ross, & Alasdair MacKenzie. (2013). Understanding the Dynamics of Gene Regulatory Systems; Characterisation and Clinical Relevance of cis-Regulatory Polymorphisms. Biology. 2(1). 64–84. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026